Correlia Launches PIXI ELISA Platform
Correlia Biosystems has developed the easy-to-use PIXI ELISA platform, an automated system for small sample volumes.
Read MorePosted by Chris Wolski | Apr 19, 2023 | Immunoassay Instrumentation |
Correlia Biosystems has developed the easy-to-use PIXI ELISA platform, an automated system for small sample volumes.
Read MorePosted by Andy Lundin | Apr 17, 2023 | Respiratory Disease |
Sapphiros was selected by the NIH RADx Tech program to develop an over-the-counter, molecular multiplex respiratory diagnostic test.
Read MorePosted by Eli Patterson | Apr 13, 2023 | Molecular Diagnostics |
Most current molecular tests have been developed as laboratory-developed tests, outside the strict regulatory framework of the FDA.
Read MorePosted by Andy Lundin | Apr 13, 2023 | Cancer |
Researchers say newly reported cases of cancer diagnoses declined 14.4% in 2020 compared with prior years.
Read MorePosted by Andy Lundin | Apr 12, 2023 | Molecular Diagnostic Analyzers |
PathogenDx expanded the reach of its patented multiplexed molecular testing technology, Dynamic Dimensional Detection (D3 Array).
Read More